Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
Cash flows from operating activities
Net loss	$ (121,816)	$ (3,213)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation		1
Stock-based compensation	828
Change in fair value of convertible promissory notes (includes related party amounts of $13,196 and $517, respectively)	51,469	517
Change in fair value of warrant liabilities - related party	43,575
Amortization of debt discount	81
Issuance of PIK interest debt	21
Acquired in-process research and development	2,500
Loss on disposal of property and equipment	42
Changes in operating assets and liabilities:
Prepaid expenses and other current assets (includes related party amounts of $(692) and $41, respectively)	(4,750)	39
Accounts payable, accrued expenses and other long-term liabilities (includes related party amounts of $(2,531) and $(59), respectively)	550	1,103
Accrued interest (includes related party amounts of $717 and $17, respectively)	2,821	17
Operating lease right-of-use assets and liabilities	754
Net cash used in operating activities	(23,925)	(1,536)
Cash flows from investing activities
Cash paid for purchased in-process research and development	(2,500)
Purchase of property and equipment		(6)
Net cash used in investing activities	(2,500)	(6)
Cash flows from financing activities
Proceeds from issuance of common stock		1
Proceeds from issuance of common stock in initial public offering	230,006
Payment of initial public offering costs	(16,569)
Proceeds from issuance of long-term debt, net of issuance costs	4,665
Proceeds from issuance of convertible promissory notes		1,750
Net cash provided by financing activities	218,102	1,751
Net increase in cash, cash equivalents and restricted cash	191,677	209
Cash and, cash equivalents and restricted cash-beginning of period	124,566	457
Cash, cash equivalents and restricted cash-end of period	316,243	$ 666
Supplemental disclosure of cash flow information
Cash paid for interest	30
Supplemental disclosure of noncash investing and financing activities
Operating lease	20,317
Unpaid initial public offering costs	1,724
Conversion of convertible promissory notes and accrued interest into common stock	215,364
Conversion of warrant liability into equity	100,020
Accreted final interest payment fees	$ 70